|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lim SL, Jia Z, Lu Y, Zhang H, Ng CT, Bay
BH, Shen HM and Ong CN: Metabolic signatures of four major
histological types of lung cancer cells. Metabolomics. 14:1182018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choi M, Kadara H, Zhang J, Parra ER,
Rodriguez-Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J,
Chow C, et al: Mutation profiles in early-stage lung squamous cell
carcinoma with clinical follow-up and correlation with markers of
immune function. Ann Oncol. 28:83–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dong J, Li B, Lin D, Zhou Q and Huang D:
Advances in targeted therapy and immunotherapy for non-small cell
lung cancer based on accurate molecular typing. Front Pharmacol.
10:2302019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chakravarthi BV, Nepal S and Varambally S:
Genomic and epigenomic alterations in cancer. Am J Pathol.
186:1724–1735. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mehta A, Dobersch S, Romero-Olmedo AJ and
Barreto G: Epigenetics in lung cancer diagnosis and therapy. Cancer
Metastasis Rev. 34:229–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfister SX and Ashworth A: Marked for
death: Targeting epigenetic changes in cancer. Nat Rev Drug Discov.
16:241–263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baylin SB and Jones PA: Epigenetic
determinants of cancer. Cold Spring Harb Perspect Biol.
8:a0195052016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bernstein BE, Meissner A and Lander ES:
The mammalian epigenome. Cell. 128:669–681. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wouters BJ and Delwel R: Epigenetics and
approaches to targeted epigenetic therapy in acute myeloid
leukemia. Blood. 127:42–52. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Győrffy B, Bottai G, Fleischer T, Munkácsy
G, Budczies J, Paladini L, Børresen-Dale AL, Kristensen VN and
Santarpia L: Aberrant DNA methylation impacts gene expression and
prognosis in breast cancer subtypes. Int J Cancer. 138:87–97. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin DC, Wang MR and Koeffler HP: Genomic
and epigenomic aberrations in esophageal squamous cell carcinoma
and implications for patients. Gastroenterology. 154:374–389. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu T, Chen D, Wang Y, Sun X, Li S, Miao S,
Wo Y, Dong Y, Leng X, Du W and Jiao W: Identification of DNA
methylation-driven genes in esophageal squamous cell carcinoma: A
study based on the cancer genome atlas. Cancer Cell Int. 19:522019.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gloss BS and Samimi G: Epigenetic
biomarkers in epithelial ovarian cancer. Cancer Lett. 342:257–263.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Villanueva A, Portela A, Sayols S,
Battiston C, Hoshida Y, Méndez-González J, Imbeaud S, Letouzé E,
Hernandez-Gea V, Cornella H, et al: DNA methylation-based prognosis
and epidrivers in hepatocellular carcinoma. Hepatology.
61:1945–1956. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tomczak K, Czerwińska P and Wiznerowicz M:
The cancer genome atlas (TCGA): An immeasurable source of
knowledge. Contemp Oncol (Pozn). 19:A68–A77. 2015.PubMed/NCBI
|
|
18
|
No authors listed, . The TCGA Legacy.
Cell. 173:281–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bibikova M, Barnes B, Tsan C, Ho V,
Klotzle B, Le JM, Delano D, Zhang L, Schroth GP, Gunderson KL, et
al: High density DNA methylation array with single CpG site
resolution. Genomics. 98:288–295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gevaert O: MethylMix: An R package for
identifying DNA methylation-driven genes. Bioinformatics.
31:1839–1841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gevaert O, Tibshirani R and Plevritis SK:
Pancancer analysis of DNA methylation-driven genes using MethylMix.
Genome Biol. 16:172015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kamburov A, Stelzl U, Lehrach H and Herwig
R: The ConsensusPathDB interaction database: 2013 update. Nucleic
Acids Res. 41:D793–D800. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamburov A, Pentchev K, Galicka H,
Wierling C, Lehrach H and Herwig R: ConsensusPathDB: Toward a more
complete picture of cell biology. Nucleic Acids Res. 39:D712–D717.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Franz M, Lopes CT, Huck G, Dong Y, Sumer O
and Bader GD: Cytoscape.js: A graph theory library for
visualisation and analysis. Bioinformatics. 32:309–311.
2016.PubMed/NCBI
|
|
25
|
Blandin Knight S, Crosbie PA, Balata H,
Chudziak J, Hussell T and Dive C: Progress and prospects of early
detection in lung cancer. Open Biol. 7:2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nebbioso A, Tambaro FP, Dell'Aversana C
and Altucci L: Cancer epigenetics: Moving forward. PLoS Genet.
14:e10073622018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu J and Yao X: Use of DNA methylation
for cancer detection: Promises and challenges. Int J Biochem Cell
Biol. 41:147–154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Leygo C, Williams M, Jin HC, Chan MWY, Chu
WK, Grusch M and Cheng YY: DNA methylation as a noninvasive
epigenetic biomarker for the detection of cancer. Dis Markers.
2017:37265952017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mase S, Shinjo K, Totani H, Katsushima K,
Arakawa A, Takahashi S, Lai HC, Lin RI, Chan MWY, Sugiura-Ogasawara
M and Kondo Y: ZNF671 DNA methylation as a molecular predictor for
the early recurrence of serous ovarian cancer. Cancer Sci.
110:1105–1116. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Eissa MAL, Lerner L, Abdelfatah E, Shankar
N, Canner JK, Hasan NM, Yaghoobi V, Huang B, Kerner Z, Takaesu F,
et al: Promoter methylation of ADAMTS1 and BNC1 as potential
biomarkers for early detection of pancreatic cancer in blood. Clin
Epigenetics. 11:592019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sun Q, Zhang W, Wang L, Guo F, Song D,
Zhang Q, Zhang D, Fan Y and Wang J: Hypermethylated CD36 gene
affected the progression of lung cancer. Gene. 678:395–406. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kiyozumi Y, Baba Y, Okadome K, Yagi T,
Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, et
al: Indoleamine 2,3-dioxygenase 1 promoter hypomethylation is
associated with a poor prognosis in patients with esophageal
cancer. Cancer Sci. 110:1863–1871. 2019.PubMed/NCBI
|
|
33
|
Carvalho RH, Hou J, Haberle V, Aerts J,
Grosveld F, Lenhard B and Philipsen S: Genomewide DNA methylation
analysis identifies novel methylated genes in non-small-cell lung
carcinomas. J Thorac Oncol. 8:562–573. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gao C, Zhuang J, Zhou C, Ma K, Zhao M, Liu
C, Liu L, Li H, Feng F and Sun C: Prognostic value of aberrantly
expressed methylation gene profiles in lung squamous cell
carcinoma: A study based on The Cancer Genome Atlas. J Cell
Physiol. 234:6519–6528. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shi YX, Wang Y, Li X, Zhang W, Zhou HH,
Yin JY and Liu ZQ: Genome-wide DNA methylation profiling reveals
novel epigenetic signatures in squamous cell lung cancer. BMC
Genomics. 18:9012017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gao C, Zhuang J, Li H, Liu C, Zhou C, Liu
L and Sun C: Exploration of methylation-driven genes for monitoring
and prognosis of patients with lung adenocarcinoma. Cancer Cell
Int. 18:1942018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xiao-Jie L, Ai-Mei G, Li-Juan J and Jiang
X: Pseudogene in cancer: Real functions and promising signature. J
Med Genet. 52:17–24. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Poliseno L, Salmena L, Zhang J, Carver B,
Haveman WJ and Pandolfi PP: A coding-independent function of gene
and pseudogene mRNAs regulates tumour biology. Nature.
465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Grandér D and Johnsson P:
Pseudogene-expressed RNAs: Emerging roles in gene regulation and
disease. Curr Top Microbiol Immunol. 394:111–126. 2016.PubMed/NCBI
|
|
40
|
Johnsson P, Ackley A, Vidarsdottir L, Lui
WO, Corcoran M, Grandér D and Morris KV: A pseudogene
long-noncoding-RNA network regulates PTEN transcription and
translation in human cells. Nat Struct Mol Biol. 20:440–446. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang Z, Liu A, Xiong Q, Xue Y, Liu F, Zeng
S, Zhang Z, Li Y, Sun Y and Xu C: Prognostic value of
differentially methylated gene profiles in bladder cancer. J Cell
Physiol. 234:18763–18772. 2019.PubMed/NCBI
|
|
42
|
Takahashi A, Seike M, Chiba M, Takahashi
S, Nakamichi S, Matsumoto M, Takeuchi S, Minegishi Y, Noro R,
Kunugi S, et al: Ankyrin repeat domain 1 overexpression is
associated with common resistance to afatinib and osimertinib in
EGFR-mutant lung cancer. Sci Rep. 8:148962018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lei Y, Henderson BR, Emmanuel C, Harnett
PR and DeFazio A: Inhibition of ANKRD1 sensitizes human ovarian
cancer cells to endoplasmic reticulum stress-induced apoptosis.
Oncogene. 34:485–495. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jen J and Wang YC: Zinc finger proteins in
cancer progression. J Biomed Sci. 23:532016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xiang S, Xiang T, Xiao Q, Li Y, Shao B and
Luo T: Zinc-finger protein 545 is inactivated due to promoter
methylation and functions as a tumor suppressor through the
Wnt/β-catenin, PI3K/AKT and MAPK/ERK signaling pathways in
colorectal cancer. Int J Oncol. 51:801–811. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Weigel C, Chaisaingmongkol J, Assenov Y,
Kuhmann C, Winkler V, Santi I, Bogatyrova O, Kaucher S, Bermejo JL,
Leung SY, et al: DNA methylation at an enhancer of the three prime
repair exonuclease 2 gene (TREX2) is linked to gene expression and
survival in laryngeal cancer. Clin Epigenetics. 11:672019.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pogribny IP, Pogribna M, Christman JK and
James SJ: Single-site methylation within the p53 promoter region
reduces gene expression in a reporter gene construct: Possible in
vivo relevance during tumorigenesis. Cancer Res. 60:588–594.
2000.PubMed/NCBI
|
